Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Fms-Like Tyrosine Kinase 3

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Fms-Like Tyrosine Kinase 3:

Pubmed Logo
Fms-Like Tyrosine Kinase 3 Ligand Regulates Migratory Pattern and Antigen Uptake of Lung Dendritic Cell Subsets in a Murine Model of Allergic Airway Inflammation.
Fms-like tyrosine kinase 3 ligand (Flt3L) reverses the features of...
18th November, 2009
Departments of. J Immunol. 2009 Dec 1;183(11):7531-7538. Epub 2009 Nov 16.
DOI Direct Link
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
PURPOSE: Cytogenetics is the primary outcome predictor in acute myeloid...
18th November, 2009
Department of Translational Hematology and Oncology Research, Taussig J Clin Oncol. 2009 Nov 1;27(31):5219-26. Epub 2009 Sep 21.
DOI Direct Link
Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies.
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits...
10th November, 2009
Oncology Unit, Third Department of Medicine, Athens University School of BioDrugs. 2009;23(6):377-89. doi: 10.2165/11318860-000000000-00000.
DOI Direct Link
Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse.
Mutations of Fms-like tyrosine kinase-3 (FLT3) have been described in...
3rd November, 2009
Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Leuk Res. 2009 Oct 28.
DOI Direct Link
Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection.
BACKGROUND: Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic...
22nd October, 2009
Department of Microbiology and Immunology, University of Texas Medical BMC Immunol. 2009 Aug 28;10:47.
DOI Direct Link

View more research publications.

Press Releases About Fms-Like Tyrosine Kinase 3:

BioPortfolio Logo
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 24th November, 2009 Ambit Biosciences Corporation
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer 9th November, 2009 AETERNA ZENTARIS INC.
Article published in December 2009 issue of the Journal of Urology QUEBEC CITY, Nov. 9 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global
Caliper Life Sciences Conducts Forum on Accelerating Small Molecule Research Programs 22nd October, 2009 Caliper Life Sciences, Inc.
HOPKINTON, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, last week held
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 20th October, 2009 Novartis
12. Jabbour E, Cortes J, Kantarjian H, et al. Molecular Monitoring in Chronic Myeloid Leukemia Response to Tyrosine Kinase Inhibitors and Prognostic Implications. Cancer. DOI10
New Report Just Published: World Multiple Myeloma Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Multiple Myeloma Therapeutics Market http://www.reportlinker.com/p0119496/World

Fms-Like Tyrosine Kinase 3 Patents:

USPTO Logo
US Patent No.Title
6846630 Nucleic acid encoding receptor type protein kinase
7202029 Nucleic acids encoding human TANGO 195
7270987 Crystallization of FMS-like tyrosine kinase 3
7276371 Stimulation of hematopoietic cells in vitro
7282201 Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Fms-Like Tyrosine Kinase 3 scientists - we have details of around 77 individuals working on Fms-Like Tyrosine Kinase 3 .


This page has been viewed 419 times
Recent Search Terms used to find this page: fms-like tyrosine kinase 3 | chronic myeloid leukemia fms-like tyrosine | fms-like tyrosine kinase 3 | FMS-like tyrosine kinase 3 wiki* | fms kinase | tyrosine kinase inhibitors october 2009 | fms drug wiki | tyrosine kinase inhibitors october 2009 | FMS-like | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Fms-Like Tyrosine Kinase 3 across BioPortfolio, or for Fms-Like Tyrosine Kinase 3 Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.